News

Vancouver, Canada, July 6, 2016, Medgold Resources Corp. (TSX-V: MED) (the “Company” or “Medgold”) is pleased to announce that it has received formal approval for the proposed diamond drilling program at the Limarinho Zone at the Boticas Gold Project. Medgold is planning a 2,500m diamond drilling program, expected to commence in mid-July, targeting a gold-bearing sheeted orogenic vein system. Energold Drilling Corp. have been selected as drill contractors to complete the initial drilling program using man-portable drill rigs. Dan James, President of Medgold, said: “We are very pleased to have[…]

Vancouver, Canada, June 29, 2016, Medgold Resources Corp. (TSX-V: MED) announces that it has granted incentive stock options to its directors, officers, employees and consultants to purchase up to a total of 2,580,000 shares of Medgold exercisable for ten years at a price of $0.15 per share. About Medgold Medgold is a European-focused, TSX-V listed exploration and development company targeting gold properties in northwest Iberia and the under-explored gold provinces of southern Europe. Run by a highly experienced management team with a successful track record of building value in resource companies,[…]

Vancouver, Canada, June 21, 2016, Medgold Resources Corp. (TSX-V: MED) is pleased to advise that it has closed its previously announced non-brokered private placement financing with the issuance to Fortuna Silver Mines Inc. of 10.0 million units at $0.15 per unit, for proceeds of $1.5 million. Each unit consists of one common share of Medgold and one warrant entitling Fortuna to purchase one additional common share of Medgold at $0.15 for one year from closing. The common shares and warrants issued are subject to a resale restriction until October 18,[…]

Vancouver, Canada, June 13, 2016, Medgold Resources Corp. (TSX-V: MED) (the “Company” or “Medgold”) is pleased to announce a C$1.5-million strategic investment in the Company by Fortuna Silver Mines Inc. (“Fortuna”), a leading mid-tier precious metals miner. The private placement is part of a broader strategic alliance between Medgold and Fortuna to explore for precious metal deposits in Serbia. Subject to stock exchange approval, Fortuna will purchase 10.0 million units at $0.15 per unit, representing a premium of 36% to the closing price of Medgold’s shares on June 10. Each[…]

Vancouver, Canada, May 16, 2016, Medgold Resources Corp. (TSX-V: MED) (the “Company” or “Medgold”) is pleased to advise that it has closed its previously announced non-brokered private placement financing with the issuance of 2.0 million units at $0.10 per unit, for proceeds of $200,000. Each unit consists of one common share and one warrant entitling the holder to purchase one additional common share of the Company at $0.12 for one year from closing. The common shares and warrants issued are subject to a resale restriction until September 11, 2016. No finder’s[…]